3 Penny Stocks With Real Revenue And Stronger Balance Sheets

With US 10Y yields holding near 4.7% as of late August 2026, many large caps look fully picked over. That creates a window where financially fit penny stocks can interest investors who want growth potential but still care about balance sheet strength. This article breaks down three screened penny stocks that pair low share prices with healthier financials so you can focus your research on ideas with tighter risk controls.

The stocks covered below are just a starter sample, and the full Financially Fit Penny Stocks screen surfaced another 311 companies with similarly detailed stories that are not included here. If you want to go straight to the source and analyze this broader universe for your own highest conviction ideas, head into the Financially Fit Penny Stocks screener.

TOYO (TOYO)

TOYO is a young Tokyo based solar manufacturer that runs the full chain from wafer and silicon production through to solar cells and finished PV modules. This is the clearest link to the Financially Fit Penny Stocks solar theme. Its reported revenue of about US$549 million comes from a single Machinery & Industrial Equipment segment, with the US a major end market, so investors are still dealing with a relatively focused business model. The stock has a market cap of roughly US$206 million, which keeps it firmly in penny stock territory.

Investors looking at TOYO get direct exposure to the solar supply chain through its PV cell and module manufacturing in the US and Asia, backed by a growing US footprint and tax credit eligible projects. The company has been labelled as having high quality earnings and strong returns on equity, yet the share price has been highly volatile and the funding mix leans heavily on external liabilities. Add in a very new management team and active capacity build out, and this results in a solar manufacturer that combines strong fundamentals with execution and financing risks that may warrant deeper research.

TOYO is ramping capacity while leaning on external funding and a fresh leadership team, which can mask where the real pressure points sit. Get the full picture in the 4 key rewards and 1 important major warning sign

Clover Health Investments (CLOV)

Clover Health Investments runs a Medicare Advantage insurance business that sells PPO and HMO plans to Medicare eligible individuals, which is the key link to the Financially Fit Penny Stocks theme because it is a recurring revenue, regulated insurance operation. The company generated about US$2.5b in insurance revenue, all from the United States, and also offers Clover Assistant, a clinical software tool for doctors that supports chronic disease management alongside the core insurance book. At a market cap of roughly US$2.2b, Clover Health sits in small cap territory while still trading at a penny stock share price.

Clover Health provides a mix of a recurring Medicare Advantage revenue stream and a physician software platform that aims to lower medical costs, all within a regulated US insurance market. Management is targeting a first full year of GAAP profitability and focusing on revenue and membership scale. At the same time, the company still reports losses and faces pressure from medical cost trends, policy changes and heavyweight competitors. For investors looking at financially focused penny stocks where the business model is already generating substantial revenue but the path to profitability remains under discussion, Clover Health is a story that may merit closer attention.

Clover Health Investments is pursuing scale in Medicare Advantage while still working through losses, which can make it difficult to identify the real inflection point. Scan the full US insurance story in the analysis report for Clover Health Investments

Hyliion Holdings (HYLN)

Hyliion Holdings develops the KARNO Power Module, a fuel flexible generator for distributed power that can run on everything from natural gas and diesel to landfill gas, renewable hydrogen and ammonia. This is its clearest link to the Financially Fit Penny Stocks theme. The company currently reports around US$9 million of revenue from Auto Parts and Accessories in the US and has a market cap of about US$595 million, so it remains a small, growth focused stock with a low share price but enterprise scale ambitions.

Hyliion is attracting attention because the KARNO Power Module is starting to secure real world validation, including multi year US Navy contracts worth about US$41.7 million and growing interest from data centers that need reliable on site power. Revenue guidance for 2026 of around US$15 million and a strong growth forecast highlight the potential. At the same time, the business is still loss making and depends on scaling complex additive manufacturing and securing critical materials, which could strain cash and require fresh capital if commercialization slips. For investors who want exposure to fuel flexible, energy transition hardware with early traction in defense and power hungry computing, Hyliion’s mix of upside and execution risk may warrant a deeper look.

Hyliion is pursuing fuel-flexible growth, while early revenue and defense interest suggest a potentially larger opportunity. Get the full story in the analyst forecasts for Hyliion Holdings

Seeking Alternatives Before The Crowd Moves

Fresh stock ideas can gain momentum quickly, and once the breakout is in motion, ideal entry points can move out of reach. Review these under the radar lists while they are still relevant.

• Spot resilient cash generators before they are widely discussed by scanning the curated list of solid balance sheet and fundamentals (51 results) and filtering for businesses that match your risk comfort zone.
• Consider the push into AI infrastructure early by reviewing the hand picked 55 AI infrastructure stocks and identifying companies that may be positioned to support growing compute demand.
• Evaluate long term electrification themes by tracking producers in the focused 9 top copper producer stocks and shortlisting stocks that fit your own return and risk targets.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com